{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:43:56Z","timestamp":1780980236008,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T00:00:00Z","timestamp":1378252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.clbc.2013.08.011","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T09:46:29Z","timestamp":1385027189000},"page":"421-432.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor\u2013Positive Breast Cancer in BOLERO-2"],"prefix":"10.1016","volume":"13","author":[{"given":"Kathleen I.","family":"Pritchard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Howard A.","family":"Burris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaker","family":"Dakhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel N.","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Campone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Cs\u00f6szi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Baselga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puttisak","family":"Puttawibul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Piccart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinzaburo","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vichien","family":"Srimuninnimit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gonzalez Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Panneerselvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Taran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Sahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gnant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2013.08.011_bib1","unstructured":"World Health Organization. Cancer: fact sheet No297. January 2013. Available\u00a0at:\u00a0http:\/\/www.who.int\/mediacentre\/factsheets\/fs297\/en\/index.html. Accessed February 25,\u00a02013."},{"key":"10.1016\/j.clbc.2013.08.011_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ije\/dyh414","article-title":"Global trends in breast cancer incidence and mortality 1973-1997","volume":"34","author":"Althuis","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clbc.2013.08.011_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1470-2045(07)70378-9","article-title":"Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology","volume":"8","author":"Wildiers","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2013.08.011_bib4","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 1.2013. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed February 25,\u00a02013."},{"key":"10.1016\/j.clbc.2013.08.011_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.breast.2006.01.007","article-title":"Postmenopausal advanced breast cancer:\u00a0options for therapy after tamoxifen and aromatase inhibitors","volume":"15","author":"Dodwell","year":"2006","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2013.08.011_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/107327480701400106","article-title":"Tolerance to chemotherapy in elderly patients with cancer","volume":"14","author":"Wedding","year":"2007","journal-title":"Cancer Control"},{"key":"10.1016\/j.clbc.2013.08.011_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2217\/WHE.12.18","article-title":"Treatment of metastatic breast cancer in women aged 65 years and older","volume":"8","author":"Jolly","year":"2012","journal-title":"Womens Health (Lond Engl)"},{"key":"10.1016\/j.clbc.2013.08.011_bib8","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1200\/JCO.2011.38.6888","article-title":"Older women with breast cancer: slow progress, great opportunity, now is the time","volume":"29","author":"Muss","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.08.011_bib9","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1172\/JCI41680","article-title":"Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer","volume":"120","author":"Miller","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clbc.2013.08.011_bib10","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/bcr3343","article-title":"Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer","volume":"14","author":"Meric-Bernstam","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2013.08.011_bib11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/annonc\/mdm170","article-title":"Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling","volume":"18","author":"Beeram","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2013.08.011_bib12","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1158\/1078-0432.CCR-04-2402","article-title":"Dual inhibition of mTOR and estrogen receptor signaling in\u00a0vitro induces cell death in models of breast cancer","volume":"11","author":"Boulay","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2013.08.011_bib13","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1158\/1078-0432.CCR-04-0035","article-title":"Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt activity","volume":"10","author":"deGraffenried","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2013.08.011_bib14","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/j.1349-7006.2008.00955.x","article-title":"mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels","volume":"99","author":"Ghayad","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clbc.2013.08.011_bib15","series-title":"Afinitor (everolimus) prescribing information","author":"Novartis Pharmaceuticals Corporation","year":"2012"},{"key":"10.1016\/j.clbc.2013.08.011_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2013.08.011_bib17","doi-asserted-by":"crossref","unstructured":"Hortobagyi GN, Piccart M, Rugo H, et\u00a0al. Everolimus for postmenopausal women with advanced breast cancer: updated results of the BOLERO-2 phase III trial. Presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS); San Antonio, TX; December 6-10, 2011:abstract S3-S7.","DOI":"10.1158\/0008-5472.SABCS11-S3-7"},{"key":"10.1016\/j.clbc.2013.08.011_bib18","series-title":"Older Americans 2012: Key Indicators of Well-Being","author":"Federal Interagency Forum on Aging-Related Statistics","year":"2012"},{"key":"10.1016\/j.clbc.2013.08.011_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/107327480100800507","article-title":"Management of breast cancer in the older woman","volume":"8","author":"Balducci","year":"2001","journal-title":"Cancer Control"},{"key":"10.1016\/j.clbc.2013.08.011_bib20","first-page":"133","article-title":"Cancer chemotherapy in the elderly","volume":"35","author":"Balducci","year":"1987","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clbc.2013.08.011_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2013.08.011_bib22","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0\u00a0(CTCAE). Published Aug 9, 2006. Available at: http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf. Accessed January 24,\u00a02013."},{"key":"10.1016\/j.clbc.2013.08.011_bib23","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1200\/JCO.2005.11.027","article-title":"Aromatase inhibitors for breast cancer prevention","volume":"23","author":"Cuzick","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.08.011_bib24","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1200\/JCO.2011.35.8408","article-title":"Improvement in breast cancer outcomes over time: are older women missing out?","volume":"29","author":"Smith","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.08.011_bib25","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1200\/JCO.2006.10.2079","article-title":"Breast cancer in the elderly","volume":"25","author":"Crivellari","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.08.011_bib26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.285.7.885","article-title":"Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older","volume":"285","author":"Yancik","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2013.08.011_bib27","first-page":"18","article-title":"Greater risks of chemotherapy toxicity in elderly patients with cancer","volume":"1","author":"Repetto","year":"2003","journal-title":"J\u00a0Support Oncol"},{"issue":"suppl 1","key":"10.1016\/j.clbc.2013.08.011_bib28","first-page":"S286","article-title":"Phase 3 study of temsirolimus with letrozole or letrozole alone in postmenopausal women with locally advanced or metastatic breast cancer","volume":"100","author":"Chow","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2013.08.011_bib29","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1002\/cncr.25219","article-title":"Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors","volume":"116","author":"Motzer","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2013.08.011_bib30","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/jnci\/djt026","article-title":"Effect of everolimus on bone marker levels\u00a0and progressive disease in bone in BOLERO-2","volume":"105","author":"Gnant","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"15 suppl","key":"10.1016\/j.clbc.2013.08.011_bib31","article-title":"Efficacy and safety of everolimus in elderly patients (pts) with metastatic renal cell carcinoma (mRCC)","volume":"28","author":"Osanto","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.08.011_bib32","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.eururo.2011.12.057","article-title":"Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial","volume":"61","author":"Porta","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.clbc.2013.08.011_bib33","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/cncr.27469","article-title":"Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer","volume":"118","author":"Binkley","year":"2012","journal-title":"Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820913001857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820913001857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:13:06Z","timestamp":1761513186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820913001857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1526820913001857"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2013.08.011","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor\u2013Positive Breast Cancer in BOLERO-2","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2013.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}